L-Theanine
L-theanine (gamma-glutamylethylamide) is a non-protein amino acid found almost exclusively in tea (Camellia sinensis). It is marketed as a nootropic/relaxant and is often stacked with caffeine to blunt caffeine's jitteriness. Human evidence is limited to small, mostly short-duration RCTs showing modest reductions in acute stress/anxiety and small effects on sleep quality; the single largest anxiety RCT (adjunctive treatment of generalized anxiety disorder) was negative for anxiety, so efficacy is unproven for clinical anxiety. It has a benign short-term safety profile in the doses studied and no signal of hepatotoxicity, dependence, or organ toxicity in humans, but long-term safety data are essentially absent and most toxicology is preclinical. It can potentiate sedatives and antihypertensives, may lower blood pressure (relevant to those on BP medication), should not substitute for evidence-based treatment of anxiety, depression, or insomnia, and its safety in pregnancy/lactation and in children beyond a few small trials is not established. This is not a substance that builds muscle, strength, or leanness and carries no anabolic or hormonal activity.
Mechanism of action
Pharmacokinetics
Short; human pharmacokinetic data are sparse. Plasma concentrations peak roughly 30-90 minutes after oral intake and return toward baseline within about 5 hours; an elimination half-life on the order of ~1 hour is generally cited but is not well characterized in robust human studies (much PK data is preclinical/rat).
Acute subjective and EEG/physiological effects are reported within ~30-120 minutes of a single oral dose and are relatively short-lived (a few hours), consistent with rapid absorption and clearance.
Oral (tablets, capsules, chewable tablets, functional beverages); the amino acid is absorbed in the small intestine, partly via amino-acid transporters.
Absorbed intact, distributed to tissues including brain, and hydrolyzed (notably in kidney/liver) to glutamic acid/glutamate and ethylamine; parent compound and metabolites are renally excreted. Clearance appears rapid. Note: PK is characterized mainly in animals; detailed human clearance/washout data are limited.
For monitoring and washout planning, not drug-test evasion.
Physiological & performance effects
- Modest reduction of acute, situational stress and anxiety in some small RCTs (e.g., reduced subjective stress and salivary cortisol response to a cognitive stressor)
- Small improvements in some cognitive/executive and verbal-fluency measures reported in a 4-week RCT in healthy adults, but findings across trials are inconsistent
- Improved self-reported sleep satisfaction and some objective sleep-efficiency measures (e.g., in boys with ADHD), though a GAD trial found no effect on insomnia severity overall
- When combined with caffeine, attenuates caffeine-induced rise in blood pressure and, in one athlete study, reduced caffeine-associated anxiety and tachycardia while cognitive/physical performance improved (effects here are largely attributable to caffeine plus reduced side effects)
- Increases EEG/MEG alpha activity, a marker of relaxed wakefulness
- No consistent, clinically meaningful cognitive-enhancement effect when given alone in most trials
Adverse effects by system
No adverse cardiovascular effects identified in human trials. If anything, L-theanine tends to attenuate stress- and caffeine-induced blood-pressure increases, so the relevant concern is additive hypotension when combined with antihypertensives rather than any cardiotoxicity.
No signal of hepatotoxicity in humans; no clinically important liver-enzyme changes were reported in the short human trials, and a 13-week rat dietary study found no treatment-related hepatic toxicity. Human long-term hepatic data are lacking.
No androgenic, estrogenic, or gonadal-axis activity is described in the literature; L-theanine is not a hormone or SERM. No adequate human data on endocrine or HPTA effects exist, but no mechanism for HPTA suppression is known.
No adequate human data. Safety in pregnancy and lactation has not been established and use in these populations is not supported by evidence. No reproductive toxicity data in humans.
Generally well tolerated; occasional mild reports of headache, dizziness, or somnolence. No evidence of dependence, withdrawal, or abuse. Because it is anxiolytic/relaxing, additive sedation is possible with other CNS depressants. It has not been shown effective for clinical generalized anxiety disorder and should not replace psychiatric care.
No renal toxicity reported in humans. In the 13-week rat study, a small increase in renal tubular cell adenomas occurred only in high-dose females and was interpreted by the authors as more consistent with genetic predisposition than direct organ toxicity; human relevance is unknown and no human renal signal exists.
No adverse hematologic effects reported in human trials; the 13-week rat study found no consistent treatment-related hematology changes. No adequate long-term human data.
No adverse dermatologic effects reported in the human literature; no adequate data. Isolated hypersensitivity to a supplement product is theoretically possible but not documented.
HPTA suppression & recovery
Suppression: None known / not applicable
L-theanine is a non-hormonal amino acid with no known effect on the hypothalamic-pituitary-testicular/gonadal axis and no androgenic or SERM activity; there is no expected HPTA suppression and no basis for post-cycle recovery concerns. It is not a SERM and no SERM protocol applies. Any hormonal or fertility concerns should be directed to a qualified endocrinologist rather than managed with this supplement.
Monitoring
Cadence: None mandated for short-term use; if combined with BP or CNS-active medications, check blood pressure and symptoms early after starting and periodically. Reassess with a clinician if used beyond a few weeks or at doses above those studied (roughly 200-400 mg/day).
- Lightheadedness, fainting, or unusually low blood pressure
- Excessive drowsiness or sedation, especially when combined with other sedatives or alcohol
- Persistent headache or dizziness
- Any allergic reaction (rash, itching, swelling, difficulty breathing) - stop and seek care
- Worsening or unremitting anxiety, depression, or insomnia - indicates need for proper medical evaluation rather than continued self-treatment
Contraindications
- Concurrent use of antihypertensive medication (risk of additive blood-pressure lowering) without clinician oversight
- Concurrent CNS depressants/sedatives (benzodiazepines, alcohol, sedating antihistamines) due to potential additive sedation
- Pregnancy and breastfeeding (no established safety)
- Use as a substitute for evidence-based treatment of diagnosed anxiety disorder, depression, or insomnia
- Children/adolescents except under medical supervision (human data limited to a few small pediatric trials)
- Known hypersensitivity to the product or its excipients
Interaction profile
- ContraindicatedWith DNP: Additive cardiovascular strain
Check a specific combination in the interaction checker.
Reducing harm & when to stop
- Doses studied in humans are typically ~200-400 mg/day (up to 900 mg/day in a GAD trial); these ranges are reported here only with their associated evidence and risks, not as a recommendation to maximize dose.
- Do not use L-theanine as a replacement for evidence-based care of diagnosed anxiety, depression, or insomnia - the largest anxiety RCT was negative; seek a clinician for persistent symptoms.
- If you take blood-pressure or sedative/CNS-depressant medications (or drink alcohol), talk to a prescriber first because effects may be additive; monitor for lightheadedness or excess drowsiness.
- Avoid in pregnancy and breastfeeding due to absent safety data.
- Supplement product content and purity are not independently verified here and can vary between products; discard any product that causes an allergic-type reaction and seek medical care for a severe reaction.
- Stop and seek medical care for fainting, severe dizziness, allergic reaction, or unusual sedation.
- Because it is often co-formulated with caffeine or other stimulants, account for total caffeine intake and its own cardiovascular and sleep effects.
Citations (11)
Every clinical claim above is tied to a primary source. Overall evidence grade B — graded to the best available evidence for its core claims.
- 01
L-theanine is a non-protein amino acid found almost exclusively in tea and studied for stress, cognition, and sleep; a systematic review of human RCTs concluded 200-400 mg/day may assist in reducing stress and anxiety under stressful conditions, while noting the need for larger, longer trials.
ReviewPMID 31758301 ↗
- 02
200 mg/day for 4 weeks reduced stress-related symptoms (depression, trait anxiety, sleep) and improved verbal fluency and executive function in a placebo-controlled crossover RCT in healthy adults.
- 03
An L-theanine drink reduced subjective stress response to a cognitive stressor and blunted the salivary cortisol response, and increased resting alpha activity, in a double-blind placebo-controlled crossover trial.
- 04
In the largest anxiety RCT, adjunctive L-theanine (450-900 mg/day) did NOT outperform placebo for anxiety (HAMA) or insomnia severity in generalized anxiety disorder, though self-reported sleep satisfaction improved.
- 05
L-theanine 400 mg/day augmentation of antipsychotics reduced anxiety and positive/general symptoms in schizophrenia/schizoaffective disorder and was reported safe and well tolerated over 8 weeks.
- 06
L-theanine 400 mg/day improved objective sleep efficiency and was well tolerated with no significant adverse events in boys with ADHD over 6 weeks.
- 07
Theanine antagonized caffeine-induced increases in blood pressure and slowed reaction time in a randomized double-blind placebo-controlled study; theanine may be useful for reducing raised blood pressure.
- 08
Oral L-theanine attenuated stress-induced blood-pressure increases in high-responders and reduced tension-anxiety scores compared with placebo.
- 09
A 13-week OECD-compliant rat dietary study found no consistent treatment-related toxicity and established a NOAEL of 4000 mg/kg/day (highest dose tested); high-dose females showed increased renal tubular adenomas interpreted as genetic predisposition rather than direct organ toxicity.
PreclinicalDOI 10.1016/j.fct.2006.03.014 ↗
- 10
Beneficial cognitive/mood effects of tea constituents are seen mainly with caffeine plus L-theanine combined rather than either alone; green tea/L-theanine can reduce anxiety and modestly benefit attention/memory.
- 11
Caffeine plus L-theanine (3 mg/kg each) reduced caffeine-associated anxiety and tachycardia while performance improved in elite wrestlers, indicating theanine mitigates caffeine side effects.
Last reviewed 2026-07-06 · Verified against PubMed · Educational, not medical advice